Point of Care and Rapid Diagnostics Market worth $72.0 billion by 2027 – Exclusive Report by MarketsandMarkets™
2 min readAuthor of the article:
Publishing date:
Apr 04, 2022 • 14 minutes ago • 4 minute read • Join the conversation
Article content
The Latin America market is expected to grow at the highest CAGR during the forecast period
Northbrook, April 04, 2022 (GLOBE NEWSWIRE) — According to the new market research report “Point of Care and Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy Test), Platform (Microfluidics, Dipsticks), Mode of Purchase (OTC, Prescription), End User (Pharmacy, Hospital, Home) – Global Forecast to 2027″, published by MarketsandMarkets™, the global Point of Care Diagnostics Market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027.
Advertisement 2
Article content
Browse in-depth TOC on “Point of Care and Rapid Diagnostics Market”
269 – Tables
42 – Figures
344 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185
The Rapid Diagnostics Market growth is mainly driven by the high prevalence of infectious diseases, supportive government policies and rising number of CLIA-waived POC tests. In addition, healthcare decentralization and greater investments and funding for product development are expected to offer growth opportunities for players in the POC Diagnostics Market. However, issues related to pricing pressure owing to reimbursement cuts and budget constraints are expected to hinder the growth of the point of care diagnostics…
GlobeNewswire
2022-04-04 14:20:32
All news and articles are copyrighted to the respective authors and/or News Broadcasters. VIXC.Com is an independent Online News Aggregator
Read more from original source here…
